SB
BSX icon

Strategic Blueprint’s Boston Scientific BSX Stock Holding History

Strategic Blueprint’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,323
Closed -$617K – 665
2025
Q3 		$617K Buy
+6,323
New +$655K 0.03% 434
2021
Q3 		– Sell
-129
Closed -$6K – 517
2021
Q2 		$6K Buy
+129
New +$5.43K ﹤0.01% 1038

Other funds holding BSX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Strategic Blueprint's BSX Position: Q4 2025 in Review

Strategic Blueprint sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 6,323 shares — an estimated $617K sold.

Strategic Blueprint first reported a position in BSX in Q2 2021 and held it in 2 quarters. The position peaked at $617K in Q3 2025. 1,784 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

  • Strategic Blueprint reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
  • Strategic Blueprint sold 6,323 Boston Scientific shares in Q4 2025, an estimated $617K.
  • Strategic Blueprint first reported a position in Boston Scientific in Q2 2021 and held it in 2 quarters.
  • Strategic Blueprint's Boston Scientific position peaked at $617K in Q3 2025.
  • 1,784 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Strategic Blueprint's 13F filing for Q4 2025, filed 30 Jan 2026.